Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +39.07%
#2 Siren Siren +30.71%
#3 Purr Purr +24.34%
#4 OriginTrail OriginTrail +16.72%
#5 UnifAI Network UnifAI Network +14.60%
#6 Tutorial Tutorial +14.15%
#7 Official Trump Official Trump +13.39%
#8 龙虾 (Lobster) 龙虾 (Lobster) +12.33%
#9 Prom Prom +11.74%
#10 Collect on Fanable Collect on Fanable +11.67%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Classifica tra le azioni #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Prezzo delle azioni
$50.82
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$102.09M
Variazione (1 giorno)
1.90%
Variazione (1 anno)
-
Paese
US
Scambia Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Categoria

Healthcare
Storico del prezzo dell'azione per Hemab Therapeutics Holdings, Inc. Common Stock (COAG)
Prezzo di chiusura più alto: $50.63 il 2026-08-01

Prezzo di chiusura più basso: $27.02 il 2026-05-01
Storico del prezzo dell'azione di Hemab Therapeutics Holdings, Inc. Common Stock dal 2026 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
Non abbastanza dati per le date fornite.
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH